Ireland’s EU drug-buying partnership secures first deal

Ireland’s EU drug-buying partnership secures first deal

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy

The European partnership that aims to jointly negotiate pharmaceutical deals has reached its first collective pricing agreement.

The drug which the partnership agreed to fund is called Spinraza, which is used to treat Spinal Muscular Atrophy.

Spinraza is already being funded by the HSE in Ireland.

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post